Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
暂无分享,去创建一个
T. Hickish | C. Boni | J. Tabernero | J. Bridgewater | A. de Gramont | P. Clingan | T. André | L. Mounedji-Boudiaf | M. Navarro | C. Topham | M. Zaninelli | I. Tabah-Fisch
[1] G. Elfenbein. Stem-cell transplantation for high-risk breast cancer. , 2003, The New England journal of medicine.
[2] L. Sobin,et al. Colon and Rectum , 1998 .
[3] O. Bouché,et al. Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] H. Rockette,et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Daniel J Sargent,et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] 岩崎 順子,et al. Oxaliplatin,fluorouracil,and leucovorin as adjuvant treatment for colon cancer.Andre T,et al.for Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators.N Engl J Med 2004;350:2343-51.PMID:15175436--大腸癌の術後補助化学療法で、初めて多剤併 , 2004 .
[7] A. Zaniboni,et al. Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[9] Marco Lorenzi,et al. Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. , 1994, Gastroenterology.
[10] Marc Buyse,et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] T R Fleming,et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.
[12] D. Obrand,et al. Incidence and patterns of recurrence following curative resection for colorectal carcinoma , 1997, Diseases of the colon and rectum.
[13] M. Kahn,et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Beahrs Oh,et al. The American Joint Committee on Cancer. , 1984 .
[15] M. Espié,et al. Phase I study of oxaliplatin in patients with advanced cancer , 2004, Cancer Chemotherapy and Pharmacology.
[16] P. Rougier,et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] J. Ferlay,et al. Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .
[18] H. Wieand,et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] H. Rockette,et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M. Buyse,et al. Should Dukes' B patients receive adjuvant therapy? A statistical perspective. , 2001, Seminars in oncology.
[21] C. Tournigand,et al. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] E. Van Cutsem,et al. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] S. Marsoni,et al. Fluorouracil and folinic acid in colon cancer , 1995, The Lancet.
[24] C. Wilson,et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] F. Lévi,et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Bryant,et al. Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05. , 1998, Journal of the National Cancer Institute.
[27] C. Erlichman. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J. P. Pignon,et al. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators , 1995, The Lancet.
[29] H. Rockette,et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.